ARCHIVES

Alimta Granted Approval As NSCLC Continuation Therapy

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | November 25, 2011

Download PDF Visit The Full Archive

Related Articles

Dendreon Claims “Clear Hit” On Provenge, But Skeptics Await Data Presentation

April 17, 2009

NCCS Networker Volume 8 Issue 1, Spring 1994

April 13, 1994

NCI, Dept. of Veteran’s Affairs Sign Agreement On Clinical Trials Access

November 1, 1996

Program Announcement For Clinical Research

February 29, 1980

NCI, IARC Sponsors Workshop On EBV

February 14, 1975

NCI Cooperative Group, Cancer Center Trials Listed

July 25, 2008